Sundrug Co.,Ltd.

TSE:9989 Stock Report

Market Cap: JP¥462.1b

SundrugLtd Balance Sheet Health

Financial Health criteria checks 5/6

SundrugLtd has a total shareholder equity of ¥260.8B and total debt of ¥34.4B, which brings its debt-to-equity ratio to 13.2%. Its total assets and total liabilities are ¥420.0B and ¥159.2B respectively. SundrugLtd's EBIT is ¥41.6B making its interest coverage ratio -705.1. It has cash and short-term investments of ¥63.4B.

Key information

13.2%

Debt to equity ratio

JP¥34.42b

Debt

Interest coverage ratio-705.1x
CashJP¥63.39b
EquityJP¥260.76b
Total liabilitiesJP¥159.23b
Total assetsJP¥419.99b

Recent financial health updates

Is SundrugLtd (TSE:9989) Using Too Much Debt?

Dec 09
Is SundrugLtd (TSE:9989) Using Too Much Debt?

Recent updates

SundrugLtd's (TSE:9989) Dividend Will Be ¥65.00

Dec 11
SundrugLtd's (TSE:9989) Dividend Will Be ¥65.00

Is SundrugLtd (TSE:9989) Using Too Much Debt?

Dec 09
Is SundrugLtd (TSE:9989) Using Too Much Debt?

Here's Why We Think SundrugLtd (TSE:9989) Is Well Worth Watching

Nov 18
Here's Why We Think SundrugLtd (TSE:9989) Is Well Worth Watching

Investors Could Be Concerned With SundrugLtd's (TSE:9989) Returns On Capital

Nov 05
Investors Could Be Concerned With SundrugLtd's (TSE:9989) Returns On Capital

Sundrug Co.,Ltd.'s (TSE:9989) Intrinsic Value Is Potentially 31% Above Its Share Price

Sep 25
Sundrug Co.,Ltd.'s (TSE:9989) Intrinsic Value Is Potentially 31% Above Its Share Price

Sundrug Co.,Ltd.'s (TSE:9989) Business Is Yet to Catch Up With Its Share Price

Sep 11
Sundrug Co.,Ltd.'s (TSE:9989) Business Is Yet to Catch Up With Its Share Price

SundrugLtd's (TSE:9989) Upcoming Dividend Will Be Larger Than Last Year's

Aug 29
SundrugLtd's (TSE:9989) Upcoming Dividend Will Be Larger Than Last Year's

SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

Jul 26
SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

Jul 12
SundrugLtd (TSE:9989) Will Pay A Larger Dividend Than Last Year At ¥65.00

Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

Jun 28
Analyst Estimates: Here's What Brokers Think Of Sundrug Co.,Ltd. (TSE:9989) After Its Yearly Report

SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth

Jun 06
SundrugLtd (TSE:9989) Ticks All The Boxes When It Comes To Earnings Growth

Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up

May 11
Sundrug Co.,Ltd.'s (TSE:9989) Share Price Not Quite Adding Up

Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital

Apr 10
Be Wary Of SundrugLtd (TSE:9989) And Its Returns On Capital

SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00

Mar 11
SundrugLtd (TSE:9989) Will Pay A Dividend Of ¥57.00

Financial Position Analysis

Short Term Liabilities: 9989's short term assets (¥202.6B) exceed its short term liabilities (¥116.5B).

Long Term Liabilities: 9989's short term assets (¥202.6B) exceed its long term liabilities (¥42.7B).

Debt to Equity History and Analysis

Debt Level: 9989 has more cash than its total debt.

Reducing Debt: 9989's debt to equity ratio has increased from 0% to 13.2% over the past 5 years.

Debt Coverage: 9989's debt is well covered by operating cash flow (107.4%).

Interest Coverage: 9989 earns more interest than it pays, so coverage of interest payments is not a concern.

Balance Sheet

Discover healthy companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/25 19:32
End of Day Share Price 2024/12/25 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Sundrug Co.,Ltd. is covered by 17 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daisuke MatsumotoBarclays
Arashi NishizawaBofA Global Research
Mayumi OginoCitigroup Inc